146 related articles for article (PubMed ID: 6419237)
21. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
[TBL] [Abstract][Full Text] [Related]
22. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion].
Wu JF; Liu TP
Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438
[TBL] [Abstract][Full Text] [Related]
23. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media.
Paajanen H; Kormano M; Uotila P
Invest Radiol; 1984; 19(4):333-7. PubMed ID: 6434489
[TBL] [Abstract][Full Text] [Related]
24. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
25. A new approach to antithrombotic therapy--evaluation of combined therapy of thromboxane synthetase inhibitor and very low dose of aspirin.
Nagatsuka K; Uyama O; Nakabayashi S; Yoneda S; Kimura K; Kamada T
Stroke; 1985; 16(5):806-9. PubMed ID: 3931302
[TBL] [Abstract][Full Text] [Related]
26. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
Srivastava KC
Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
[TBL] [Abstract][Full Text] [Related]
27. Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man.
Küster LJ; Frölich JC
Prostaglandins; 1986 Sep; 32(3):415-23. PubMed ID: 3097760
[TBL] [Abstract][Full Text] [Related]
28. Platelet function in experimentally induced pancreatitis in the dog.
Jacobs RM; Murtaugh RJ; Fertel RH
Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
[TBL] [Abstract][Full Text] [Related]
29. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2.
Nishizawa EE; Williams DJ; Connell CL
Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025
[TBL] [Abstract][Full Text] [Related]
30. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation.
Asbóth G; Gimes G; Hertelendy F; Tóth M
Biochim Biophys Acta; 1989 Mar; 1002(1):101-8. PubMed ID: 2493805
[TBL] [Abstract][Full Text] [Related]
31. Arachidonic acid-induced platelet aggregation and prostanoid formation in whole blood in relation to plasma concentration of indomethacin.
Vinge E
Eur J Clin Pharmacol; 1985; 28(2):163-9. PubMed ID: 3921386
[TBL] [Abstract][Full Text] [Related]
32. Effect of intravenous infusion of OKY-1581 (sodium-(E)-3-[4-(3-pyridylmethyl)phenyl] -2-methylacrylate) on circulatory thromboxane A2 and prostacyclin levels in anaesthetized baboon.
Roy AC; Adaikan PG; Karim SM
Prostaglandins Med; 1981 Sep; 7(3):253-9. PubMed ID: 7029585
[No Abstract] [Full Text] [Related]
33. Sudden death induced by intracoronary platelet aggregation.
Yamazaki H; Isohisa I; Tanoue K
Jpn Circ J; 1983 May; 47(5):596-607. PubMed ID: 6406715
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
Bertelé V; Falanga A; Tomasiak M; Chiabrando C; Cerletti C; de Gaetano G
Blood; 1984 Jun; 63(6):1460-6. PubMed ID: 6426554
[TBL] [Abstract][Full Text] [Related]
35. OKY-046 inhibits thromboxane synthesis with no effect on brain edema and neurological status in head traumatized rats.
Shapira Y; Yadid G; Cotev S; Shohami E
Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):49-55. PubMed ID: 2740414
[TBL] [Abstract][Full Text] [Related]
36. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
Qu YZ; Wang YE; Li XX
Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
[TBL] [Abstract][Full Text] [Related]
37. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron.
Farman N; Pradelles P; Bonvalet JP
Am J Physiol; 1987 Jan; 252(1 Pt 2):F53-9. PubMed ID: 3101513
[TBL] [Abstract][Full Text] [Related]
38. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
Edmonds LC; Lefer AM
Life Sci; 1984 Oct; 35(17):1763-8. PubMed ID: 6434893
[TBL] [Abstract][Full Text] [Related]
39. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs.
Ishihara Y; Uchida Y; Kitamura S
Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388
[TBL] [Abstract][Full Text] [Related]
40. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
